Evaluation of Ocular Side Effects in the Patients on Topiramate Therapy for Control of Migrainous Headache.

Date
2016-MarAuthor
Omid Hesami
Seyedeh Simindokht Hosseini
Nasim Kazemi
Seyed-Mostafa Hosseini-Zijoud
Nahid Beladi Moghaddam
Farhad Assarzadegan
Sara Mokhtari
Shahrzad Fakhraee
Metadata
Show full item recordAbstract
Topiramate, a sulfa-derivative monosaccharide, is an antiepileptic drug which is administered in the control of migraine. It is reported to cause various ocular side effects such as visual field defect and myopic shift. To investigate the alterations in refractive error, properties of the cornea and changes in the anterior chamber in patients that receive Topiramate for migraine control.